Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/4551Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | M Akhila | - |
| dc.date.accessioned | 2026-05-20T06:57:31Z | - |
| dc.date.available | 2026-05-20T06:57:31Z | - |
| dc.date.issued | 2026-05-20 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/4551 | - |
| dc.description | Vol21, No.2 , p 8 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Ovarian cancer | en_US |
| dc.subject | DNA damage response | en_US |
| dc.subject | Homologous recombination deficiency | en_US |
| dc.subject | BRCA mutations | en_US |
| dc.subject | Replication fork protection | en_US |
| dc.subject | Precision oncology | en_US |
| dc.title | PARP Inhibitor resiatance in overian cancer : mechanisms, biomarkers, and therapentic strategies | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol21, No.2 , 2026 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.